"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","treatment_protocol_ch1","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_email","contact_phone","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","cell line:ch1","duration:ch1","group:ch1","perturbagen:ch1"
"GSM2286188","MCF7_Glycyrrhizic acid_10μM_rep1.1-1","GSM2286188","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Glycyrrhizic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286188/suppl/GSM2286188_BH13047-2_1-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Glycyrrhizic acid"
"GSM2286189","MCF7_Glycyrrhizic acid_10μM_rep2.1-2","GSM2286189","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Glycyrrhizic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286189/suppl/GSM2286189_BH13047-2_1-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Glycyrrhizic acid"
"GSM2286190","MCF7_Hydroxysafflor yellow A_10μM_rep1","GSM2286190","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Hydroxysafflor yellow A","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286190/suppl/GSM2286190_BH13047-2_2-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Hydroxysafflor yellow A"
"GSM2286191","MCF7_Hydroxysafflor yellow A_10μM_rep2","GSM2286191","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Hydroxysafflor yellow A","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286191/suppl/GSM2286191_BH13047-2_2-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Hydroxysafflor yellow A"
"GSM2286192","MCF7_Anhydroicaritin_10μM_rep1","GSM2286192","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Anhydroicaritin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286192/suppl/GSM2286192_BH13047-2_3-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Anhydroicaritin"
"GSM2286193","MCF7_Anhydroicaritin_10μM_rep2","GSM2286193","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Anhydroicaritin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286193/suppl/GSM2286193_BH13047-2_3-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Anhydroicaritin"
"GSM2286194","MCF7_Hyperoside_10μM_rep1","GSM2286194","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Hyperoside","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286194/suppl/GSM2286194_BH13047-2_4-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Hyperoside"
"GSM2286195","MCF7_Hyperoside_10μM_rep2","GSM2286195","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Hyperoside","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286195/suppl/GSM2286195_BH13047-2_4-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Hyperoside"
"GSM2286196","MCF7_Hesperidin_10μM_rep1","GSM2286196","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Hesperidin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286196/suppl/GSM2286196_BH13047-2_5-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Hesperidin"
"GSM2286197","MCF7_Hesperidin_10μM_rep2","GSM2286197","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Hesperidin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286197/suppl/GSM2286197_BH13047-2_5-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Hesperidin"
"GSM2286198","MCF7_Puerarin_10μM_rep1","GSM2286198","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Puerarin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286198/suppl/GSM2286198_BH13047-2_6-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Puerarin"
"GSM2286199","MCF7_Puerarin_10μM_rep2","GSM2286199","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Puerarin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286199/suppl/GSM2286199_BH13047-2_6-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Puerarin"
"GSM2286200","MCF7_Aconitine_10μM_rep1","GSM2286200","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Aconitine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286200/suppl/GSM2286200_BH13047-2_7-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Aconitine"
"GSM2286201","MCF7_Aconitine_10μM_rep2","GSM2286201","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Aconitine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286201/suppl/GSM2286201_BH13047-2_7-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Aconitine"
"GSM2286202","MCF7_Stachydrine hydrochloride_10μM_rep1","GSM2286202","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Stachydrine hydrochloride","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286202/suppl/GSM2286202_BH13047-2_8-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Stachydrine hydrochloride"
"GSM2286203","MCF7_Stachydrine hydrochloride_10μM_rep2","GSM2286203","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Stachydrine hydrochloride","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286203/suppl/GSM2286203_BH13047-2_8-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Stachydrine hydrochloride"
"GSM2286204","MCF7_Ephedrine hydrochloride_10μM_rep1","GSM2286204","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ephedrine hydrochloride","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286204/suppl/GSM2286204_BH13047-2_9-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ephedrine hydrochloride"
"GSM2286205","MCF7_Ephedrine hydrochloride_10μM_rep2","GSM2286205","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ephedrine hydrochloride","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286205/suppl/GSM2286205_BH13047-2_9-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ephedrine hydrochloride"
"GSM2286206","MCF7_Berberine hydrochloride_10μM_rep1","GSM2286206","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Berberine hydrochloride","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286206/suppl/GSM2286206_BH13047-2_10-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Berberine hydrochloride"
"GSM2286207","MCF7_Berberine hydrochloride_10μM_rep2","GSM2286207","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Berberine hydrochloride","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286207/suppl/GSM2286207_BH13047-2_10-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Berberine hydrochloride"
"GSM2286208","MCF7_Ginkgolide B_10μM_rep1","GSM2286208","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ginkgolide B","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286208/suppl/GSM2286208_BH13047-2_11-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ginkgolide B"
"GSM2286209","MCF7_Ginkgolide B_10μM_rep2","GSM2286209","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ginkgolide B","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286209/suppl/GSM2286209_BH13047-2_11-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ginkgolide B"
"GSM2286210","MCF7_Bilobalide_10μM_rep1","GSM2286210","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Bilobalide","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286210/suppl/GSM2286210_BH13047-2_12-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Bilobalide"
"GSM2286211","MCF7_Bilobalide_10μM_rep2","GSM2286211","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Bilobalide","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286211/suppl/GSM2286211_BH13047-2_12-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Bilobalide"
"GSM2286212","MCF7_Andrographolide_10μM_rep1","GSM2286212","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Andrographolide","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286212/suppl/GSM2286212_BH13047-2_13-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Andrographolide"
"GSM2286213","MCF7_Andrographolide_10μM_rep2","GSM2286213","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Andrographolide","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286213/suppl/GSM2286213_BH13047-2_13-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Andrographolide"
"GSM2286214","MCF7_Paeoniflorin_10μM_rep1","GSM2286214","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Paeoniflorin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286214/suppl/GSM2286214_BH13047-2_14-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Paeoniflorin"
"GSM2286215","MCF7_Paeoniflorin_10μM_rep2","GSM2286215","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Paeoniflorin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286215/suppl/GSM2286215_BH13047-2_14-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Paeoniflorin"
"GSM2286216","MCF7_Tanshinone IIA_10μM_rep1","GSM2286216","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Tanshinone IIA","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286216/suppl/GSM2286216_BH13047-2_15-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Tanshinone IIA"
"GSM2286217","MCF7_Tanshinone IIA_10μM_rep2","GSM2286217","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Tanshinone IIA","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286217/suppl/GSM2286217_BH13047-2_15-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Tanshinone IIA"
"GSM2286218","MCF7_Lobetyolin_10μM_rep1","GSM2286218","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Lobetyolin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286218/suppl/GSM2286218_BH13082-3_16-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Lobetyolin"
"GSM2286219","MCF7_Lobetyolin_10μM_rep2","GSM2286219","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Lobetyolin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286219/suppl/GSM2286219_BH13082-3_16-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Lobetyolin"
"GSM2286220","MCF7_Emodin_10μM_rep1","GSM2286220","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Emodin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286220/suppl/GSM2286220_BH13082-3_17-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Emodin"
"GSM2286221","MCF7_Emodin_10μM_rep2","GSM2286221","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Emodin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286221/suppl/GSM2286221_BH13082-3_17-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Emodin"
"GSM2286222","MCF7_Ginsenoside Rg1_10μM_rep1","GSM2286222","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ginsenoside Rg1","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286222/suppl/GSM2286222_BH13082-3_18-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ginsenoside Rg1"
"GSM2286223","MCF7_Ginsenoside Rg1_10μM_rep2","GSM2286223","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ginsenoside Rg1","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286223/suppl/GSM2286223_BH13082-3_18-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ginsenoside Rg1"
"GSM2286224","MCF7_Ginsenoside Rb1_10μM_rep1","GSM2286224","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ginsenoside Rb1","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286224/suppl/GSM2286224_BH13082-3_19-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ginsenoside Rb1"
"GSM2286225","MCF7_Ginsenoside Rb1_10μM_rep2","GSM2286225","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ginsenoside Rb1","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286225/suppl/GSM2286225_BH13082-3_19-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ginsenoside Rb1"
"GSM2286226","MCF7_Astragaloside IV_10μM_rep1","GSM2286226","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Astragaloside IV","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286226/suppl/GSM2286226_BH13082-3_20-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Astragaloside IV"
"GSM2286227","MCF7_Astragaloside IV_10μM_rep2","GSM2286227","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Astragaloside IV","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286227/suppl/GSM2286227_BH13082-3_20-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Astragaloside IV"
"GSM2286228","MCF7_Saikosaponin A_10μM_rep1","GSM2286228","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Saikosaponin A","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286228/suppl/GSM2286228_BH13082-3_21-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Saikosaponin A"
"GSM2286229","MCF7_Saikosaponin A_10μM_rep2","GSM2286229","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Saikosaponin A","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286229/suppl/GSM2286229_BH13082-3_21-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Saikosaponin A"
"GSM2286230","MCF7_Saikosaponin D_10μM_rep1","GSM2286230","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Saikosaponin D","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286230/suppl/GSM2286230_BH13082-3_22-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Saikosaponin D"
"GSM2286231","MCF7_Saikosaponin D_10μM_rep2","GSM2286231","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Saikosaponin D","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286231/suppl/GSM2286231_BH13082-3_22-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Saikosaponin D"
"GSM2286232","MCF7_Salvianolic acid B_10μM_rep1","GSM2286232","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Salvianolic acid B","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286232/suppl/GSM2286232_BH13082-3_23-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Salvianolic acid B"
"GSM2286233","MCF7_Salvianolic acid B_10μM_rep2","GSM2286233","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Salvianolic acid B","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286233/suppl/GSM2286233_BH13082-3_23-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Salvianolic acid B"
"GSM2286234","MCF7_Chlorogenic acid_10μM_rep1","GSM2286234","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Chlorogenic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286234/suppl/GSM2286234_BH13082-3_24-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Chlorogenic acid"
"GSM2286235","MCF7_Chlorogenic acid_10μM_rep2","GSM2286235","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Chlorogenic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286235/suppl/GSM2286235_BH13082-3_24-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Chlorogenic acid"
"GSM2286236","MCF7_Ferulic acid_10μM_rep1","GSM2286236","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ferulic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286236/suppl/GSM2286236_BH13082-3_25-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ferulic acid"
"GSM2286237","MCF7_Ferulic acid_10μM_rep2","GSM2286237","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ferulic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286237/suppl/GSM2286237_BH13082-3_25-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ferulic acid"
"GSM2286238","MCF7_Gastrodin_10μM_rep1","GSM2286238","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Gastrodin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286238/suppl/GSM2286238_BH13082-3_26-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Gastrodin"
"GSM2286239","MCF7_Gastrodin_10μM_rep2","GSM2286239","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Gastrodin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286239/suppl/GSM2286239_BH13082-3_26-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Gastrodin"
"GSM2286240","MCF7_Acteoside_10μM_rep1","GSM2286240","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Acteoside","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286240/suppl/GSM2286240_BH13082-3_27-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Acteoside"
"GSM2286241","MCF7_Acteoside_10μM_rep2","GSM2286241","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Acteoside","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286241/suppl/GSM2286241_BH13082-3_27-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Acteoside"
"GSM2286242","MCF7_Imperatorin_10μM_rep1","GSM2286242","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Imperatorin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286242/suppl/GSM2286242_BH13082-3_28-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Imperatorin"
"GSM2286243","MCF7_Imperatorin_10μM_rep2","GSM2286243","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Imperatorin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286243/suppl/GSM2286243_BH13082-3_28-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Imperatorin"
"GSM2286244","MCF7_Artemisinin_10μM_rep1","GSM2286244","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Artemisinin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286244/suppl/GSM2286244_BH13082-3_29-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Artemisinin"
"GSM2286245","MCF7_Artemisinin_10μM_rep2","GSM2286245","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Artemisinin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286245/suppl/GSM2286245_BH13082-3_29-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Artemisinin"
"GSM2286246","MCF7_Resveratrol_10μM_rep1","GSM2286246","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Resveratrol","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286246/suppl/GSM2286246_BH13082-3_30-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Resveratrol"
"GSM2286247","MCF7_Resveratrol_10μM_rep2","GSM2286247","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Resveratrol","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286247/suppl/GSM2286247_BH13082-3_30-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Resveratrol"
"GSM2286248","MCF7_vehicle(DMSO)_rep1 [BH13248-3]","GSM2286248","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: control","perturbagen: DMSO","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286248/suppl/GSM2286248_BH13248-3_Yin-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","control","DMSO"
"GSM2286249","MCF7_vehicle(DMSO)_rep2 [BH13248-3]","GSM2286249","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: control","perturbagen: DMSO","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286249/suppl/GSM2286249_BH13248-3_Yin-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","control","DMSO"
"GSM2286250","MCF7_Hyodeoxycholic acid_10μM_rep1","GSM2286250","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Hyodeoxycholic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286250/suppl/GSM2286250_BH13083-3_2-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Hyodeoxycholic acid"
"GSM2286251","MCF7_Hyodeoxycholic acid_10μM_rep2","GSM2286251","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Hyodeoxycholic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286251/suppl/GSM2286251_BH13083-3_2-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Hyodeoxycholic acid"
"GSM2286252","MCF7_Deoxycholic acid_10μM_rep1","GSM2286252","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Deoxycholic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286252/suppl/GSM2286252_BH13083-3_3-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Deoxycholic acid"
"GSM2286253","MCF7_Deoxycholic acid_10μM_rep2","GSM2286253","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Deoxycholic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286253/suppl/GSM2286253_BH13083-3_3-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Deoxycholic acid"
"GSM2286254","MCF7_Ursodeoxycholic acid_10μM_rep1","GSM2286254","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ursodeoxycholic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286254/suppl/GSM2286254_BH13083-3_4-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ursodeoxycholic acid"
"GSM2286255","MCF7_Ursodeoxycholic acid_10μM_rep2","GSM2286255","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ursodeoxycholic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286255/suppl/GSM2286255_BH13083-3_4-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ursodeoxycholic acid"
"GSM2286256","MCF7_Chenodeoxycholic acid_10μM_rep1","GSM2286256","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Chenodeoxycholic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286256/suppl/GSM2286256_BH13083-3_5-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Chenodeoxycholic acid"
"GSM2286257","MCF7_Chenodeoxycholic acid_10μM_rep2","GSM2286257","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Chenodeoxycholic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286257/suppl/GSM2286257_BH13083-3_5-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Chenodeoxycholic acid"
"GSM2286258","MCF7_Cholic acid_10μM_rep1","GSM2286258","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Cholic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286258/suppl/GSM2286258_BH13083-3_6-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Cholic acid"
"GSM2286259","MCF7_Cholic acid_10μM_rep2","GSM2286259","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Cholic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286259/suppl/GSM2286259_BH13083-3_6-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Cholic acid"
"GSM2286260","MCF7_Cinnamic acid_10μM_rep1","GSM2286260","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Cinnamic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286260/suppl/GSM2286260_BH13083-3_7-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Cinnamic acid"
"GSM2286261","MCF7_Cinnamic acid_10μM_rep2","GSM2286261","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Cinnamic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286261/suppl/GSM2286261_BH13083-3_7-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Cinnamic acid"
"GSM2286262","MCF7_Cinnamaldehyde_10μM_rep1","GSM2286262","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Cinnamaldehyde","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286262/suppl/GSM2286262_BH13083-3_8-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Cinnamaldehyde"
"GSM2286263","MCF7_Cinnamaldehyde_10μM_rep2","GSM2286263","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Cinnamaldehyde","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286263/suppl/GSM2286263_BH13083-3_8-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Cinnamaldehyde"
"GSM2286264","MCF7_Muscone_10μM_rep1","GSM2286264","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Muscone","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286264/suppl/GSM2286264_BH13083-3_9-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Muscone"
"GSM2286265","MCF7_Muscone_10μM_rep2","GSM2286265","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Muscone","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286265/suppl/GSM2286265_BH13083-3_9-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Muscone"
"GSM2286266","MCF7_Isoborneol_10μM_rep1","GSM2286266","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Isoborneol","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286266/suppl/GSM2286266_BH13083-3_10-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Isoborneol"
"GSM2286267","MCF7_Isoborneol_10μM_rep2","GSM2286267","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Isoborneol","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286267/suppl/GSM2286267_BH13083-3_10-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Isoborneol"
"GSM2286268","MCF7_Borneol_10μM_rep1","GSM2286268","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Borneol","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286268/suppl/GSM2286268_BH13083-3_11-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Borneol"
"GSM2286269","MCF7_Borneol_10μM_rep2","GSM2286269","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Borneol","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286269/suppl/GSM2286269_BH13083-3_11-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Borneol"
"GSM2286270","MCF7_Benzyl benzoate_10μM_rep1","GSM2286270","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Benzyl benzoate","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286270/suppl/GSM2286270_BH13083-3_12-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Benzyl benzoate"
"GSM2286271","MCF7_Benzyl benzoate_10μM_rep2","GSM2286271","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Benzyl benzoate","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286271/suppl/GSM2286271_BH13083-3_12-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Benzyl benzoate"
"GSM2286272","MCF7_Ginsenoside Rb3_10μM_rep1","GSM2286272","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ginsenoside Rb3","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286272/suppl/GSM2286272_BH13083-3_13-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ginsenoside Rb3"
"GSM2286273","MCF7_Ginsenoside Rb3_10μM_rep2","GSM2286273","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ginsenoside Rb3","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286273/suppl/GSM2286273_BH13083-3_13-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ginsenoside Rb3"
"GSM2286274","MCF7_Ginsenoside Rc_10μM_rep1","GSM2286274","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ginsenoside Rc","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286274/suppl/GSM2286274_BH13083-3_14-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ginsenoside Rc"
"GSM2286275","MCF7_Ginsenoside Rc_10μM_rep2","GSM2286275","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ginsenoside Rc","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286275/suppl/GSM2286275_BH13083-3_14-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ginsenoside Rc"
"GSM2286276","MCF7_Ginsenoside Rb2_10μM_rep1","GSM2286276","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ginsenoside Rb2","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286276/suppl/GSM2286276_BH13083-3_15-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ginsenoside Rb2"
"GSM2286277","MCF7_Ginsenoside Rb2_10μM_rep2","GSM2286277","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ginsenoside Rb2","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286277/suppl/GSM2286277_BH13083-3_15-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ginsenoside Rb2"
"GSM2286278","MCF7_Ginsenoside Re_10μM_rep1","GSM2286278","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ginsenoside Re","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286278/suppl/GSM2286278_BH13083-3_16-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ginsenoside Re"
"GSM2286279","MCF7_Ginsenoside Re_10μM_rep2","GSM2286279","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ginsenoside Re","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286279/suppl/GSM2286279_BH13083-3_16-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ginsenoside Re"
"GSM2286280","MCF7_Ginsenoside Rd_10μM_rep1","GSM2286280","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ginsenoside Rd","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286280/suppl/GSM2286280_BH13083-3_17-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ginsenoside Rd"
"GSM2286281","MCF7_Ginsenoside Rd_10μM_rep2","GSM2286281","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ginsenoside Rd","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286281/suppl/GSM2286281_BH13083-3_17-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ginsenoside Rd"
"GSM2286282","MCF7_Nitidine chloride_10μM_rep1","GSM2286282","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Nitidine chloride","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286282/suppl/GSM2286282_BH13083-3_18-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Nitidine chloride"
"GSM2286283","MCF7_Nitidine chloride_10μM_rep2","GSM2286283","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Nitidine chloride","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286283/suppl/GSM2286283_BH13083-3_18-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Nitidine chloride"
"GSM2286284","MCF7_Protocatechuic aldehyde_10μM_rep1","GSM2286284","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Protocatechuic aldehyde","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286284/suppl/GSM2286284_BH13083-3_19-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Protocatechuic aldehyde"
"GSM2286285","MCF7_Protocatechuic aldehyde_10μM_rep2","GSM2286285","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Protocatechuic aldehyde","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286285/suppl/GSM2286285_BH13083-3_19-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Protocatechuic aldehyde"
"GSM2286286","MCF7_Britanin_10μM_rep1","GSM2286286","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Britanin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286286/suppl/GSM2286286_BH13083-3_20-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Britanin"
"GSM2286287","MCF7_Britanin_10μM_rep2","GSM2286287","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Britanin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286287/suppl/GSM2286287_BH13083-3_20-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Britanin"
"GSM2286288","MCF7_Japonicone A_10μM_rep1","GSM2286288","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Japonicone A","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286288/suppl/GSM2286288_BH13083-3_21-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Japonicone A"
"GSM2286289","MCF7_Japonicone A_10μM_rep2","GSM2286289","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Japonicone A","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286289/suppl/GSM2286289_BH13083-3_21-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Japonicone A"
"GSM2286290","MCF7_Bacopaside I_10μM_rep1","GSM2286290","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Bacopaside I","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286290/suppl/GSM2286290_BH13083-3_22-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Bacopaside I"
"GSM2286291","MCF7_Bacopaside I_10μM_rep2","GSM2286291","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Bacopaside I","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286291/suppl/GSM2286291_BH13083-3_22-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Bacopaside I"
"GSM2286292","MCF7_1β-hydroxyalantolactone_10μM_rep1","GSM2286292","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: 1beta-hydroxyalantolactone","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286292/suppl/GSM2286292_BH13083-3_23-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","1beta-hydroxyalantolactone"
"GSM2286293","MCF7_1β-hydroxyalantolactone_10μM_rep2","GSM2286293","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: 1beta-hydroxyalantolactone","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286293/suppl/GSM2286293_BH13083-3_23-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","1beta-hydroxyalantolactone"
"GSM2286294","MCF7_Salvianic acid A sodium_10μM_rep1","GSM2286294","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Salvianic acid A sodium","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286294/suppl/GSM2286294_BH13083-3_24-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Salvianic acid A sodium"
"GSM2286295","MCF7_Salvianic acid A sodium_10μM_rep2","GSM2286295","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Salvianic acid A sodium","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286295/suppl/GSM2286295_BH13083-3_24-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Salvianic acid A sodium"
"GSM2286296","MCF7_Isoalantolactone_10μM_rep1","GSM2286296","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Isoalantolactone","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286296/suppl/GSM2286296_BH13083-3_25-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Isoalantolactone"
"GSM2286297","MCF7_Isoalantolactone_10μM_rep2","GSM2286297","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Isoalantolactone","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286297/suppl/GSM2286297_BH13083-3_25-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Isoalantolactone"
"GSM2286298","MCF7_Alantolactone_10μM_rep1","GSM2286298","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Alantolactone","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286298/suppl/GSM2286298_BH13083-3_26-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Alantolactone"
"GSM2286299","MCF7_Alantolactone_10μM_rep2","GSM2286299","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Alantolactone","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286299/suppl/GSM2286299_BH13083-3_26-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Alantolactone"
"GSM2286300","MCF7_Resibufogenin_1μM_rep1","GSM2286300","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Resibufogenin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286300/suppl/GSM2286300_BH13083-3_27-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Resibufogenin"
"GSM2286301","MCF7_Resibufogenin_1μM_rep2","GSM2286301","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Resibufogenin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286301/suppl/GSM2286301_BH13083-3_27-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Resibufogenin"
"GSM2286302","MCF7_Bufalin_1μM_rep1","GSM2286302","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Bufalin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286302/suppl/GSM2286302_BH13083-3_28-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Bufalin"
"GSM2286303","MCF7_Bufalin_1μM_rep2","GSM2286303","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Bufalin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286303/suppl/GSM2286303_BH13083-3_28-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Bufalin"
"GSM2286304","MCF7_Gamabufatalin_1μM_rep1","GSM2286304","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Gamabufatalin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286304/suppl/GSM2286304_BH13083-3_29-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Gamabufatalin"
"GSM2286305","MCF7_Gamabufatalin_1μM_rep2","GSM2286305","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Gamabufatalin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286305/suppl/GSM2286305_BH13083-3_29-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Gamabufatalin"
"GSM2286306","MCF7_Cinobufogenin_1μM_rep1","GSM2286306","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Cinobufogenin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286306/suppl/GSM2286306_BH13083-3_30-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Cinobufogenin"
"GSM2286307","MCF7_Cinobufogenin_1μM_rep2","GSM2286307","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Cinobufogenin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286307/suppl/GSM2286307_BH13083-3_30-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Cinobufogenin"
"GSM2286308","MCF7_Arenobufagin_1μM_rep1","GSM2286308","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Arenobufagin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286308/suppl/GSM2286308_BH13083-3_31-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Arenobufagin"
"GSM2286309","MCF7_Arenobufagin_1μM_rep2","GSM2286309","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Arenobufagin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286309/suppl/GSM2286309_BH13083-3_31-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Arenobufagin"
"GSM2286310","MCF7_Telocinobufagin_1μM_rep1","GSM2286310","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Telocinobufagin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286310/suppl/GSM2286310_BH13083-3_32-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Telocinobufagin"
"GSM2286311","MCF7_Telocinobufagin_1μM_rep2","GSM2286311","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Telocinobufagin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286311/suppl/GSM2286311_BH13083-3_32-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Telocinobufagin"
"GSM2286312","MCF7_Bufotaline_1μM_rep1","GSM2286312","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Bufotaline","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286312/suppl/GSM2286312_BH13083-3_33-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Bufotaline"
"GSM2286313","MCF7_Bufotaline_1μM_rep2","GSM2286313","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Bufotaline","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286313/suppl/GSM2286313_BH13083-3_33-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Bufotaline"
"GSM2286314","MCF7_Cinobufotalin_1μM_rep1","GSM2286314","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Cinobufotalin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286314/suppl/GSM2286314_BH13083-3_34-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Cinobufotalin"
"GSM2286315","MCF7_Cinobufotalin_1μM_rep2","GSM2286315","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Cinobufotalin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286315/suppl/GSM2286315_BH13083-3_34-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Cinobufotalin"
"GSM2286316","MCF7_vehicle(DMSO)_rep1","GSM2286316","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: control","perturbagen: DMSO","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286316/suppl/GSM2286316_BH13083-3_36-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","control","DMSO"
"GSM2286317","MCF7_vehicle(DMSO)_rep2","GSM2286317","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: control","perturbagen: DMSO","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286317/suppl/GSM2286317_BH13083-3_36-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","control","DMSO"
"GSM2286318","MCF7_Salidroside_10μM_rep1","GSM2286318","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Salidroside","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286318/suppl/GSM2286318_BH13772-3_D1-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Salidroside"
"GSM2286319","MCF7_Salidroside_10μM_rep2","GSM2286319","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Salidroside","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286319/suppl/GSM2286319_BH13772-3_D1-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Salidroside"
"GSM2286320","MCF7_Daidzin_10μM_rep1","GSM2286320","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Daidzin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286320/suppl/GSM2286320_BH13772-3_D2-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Daidzin"
"GSM2286321","MCF7_Daidzin_10μM_rep2","GSM2286321","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Daidzin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286321/suppl/GSM2286321_BH13772-3_D2-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Daidzin"
"GSM2286322","MCF7_Schisantherin A_10μM_rep1","GSM2286322","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Schisantherin A","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286322/suppl/GSM2286322_BH13772-3_D3-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Schisantherin A"
"GSM2286323","MCF7_Schisantherin A_10μM_rep2","GSM2286323","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Schisantherin A","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286323/suppl/GSM2286323_BH13772-3_D3-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Schisantherin A"
"GSM2286324","MCF7_Schizandrin_10μM_rep1","GSM2286324","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Schizandrin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286324/suppl/GSM2286324_BH13772-3_D4-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Schizandrin"
"GSM2286325","MCF7_Schizandrin_10μM_rep2","GSM2286325","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Schizandrin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286325/suppl/GSM2286325_BH13772-3_D4-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Schizandrin"
"GSM2286326","MCF7_Oxymatrine_10μM_rep1","GSM2286326","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Oxymatrine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286326/suppl/GSM2286326_BH13772-3_D5-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Oxymatrine"
"GSM2286327","MCF7_Oxymatrine_10μM_rep2","GSM2286327","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Oxymatrine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286327/suppl/GSM2286327_BH13772-3_D5-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Oxymatrine"
"GSM2286328","MCF7_Matrine_10μM_rep1","GSM2286328","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Matrine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286328/suppl/GSM2286328_BH13773-3_D6-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Matrine"
"GSM2286329","MCF7_Matrine_10μM_rep2","GSM2286329","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Matrine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286329/suppl/GSM2286329_BH13773-3_D6-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Matrine"
"GSM2286330","MCF7_Osthole_10μM_rep1","GSM2286330","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Osthole","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286330/suppl/GSM2286330_BH13773-3_D7-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Osthole"
"GSM2286331","MCF7_Osthole_10μM_rep2","GSM2286331","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Osthole","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286331/suppl/GSM2286331_BH13773-3_D7-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Osthole"
"GSM2286332","MCF7_Silybin_10μM_rep1","GSM2286332","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Silybin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286332/suppl/GSM2286332_BH13773-3_D8-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Silybin"
"GSM2286333","MCF7_Silybin_10μM_rep2","GSM2286333","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Silybin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286333/suppl/GSM2286333_BH13773-3_D8-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Silybin"
"GSM2286334","MCF7_Oleanic acid_10μM_rep1","GSM2286334","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Oleanic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286334/suppl/GSM2286334_BH13773-3_D9-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Oleanic acid"
"GSM2286335","MCF7_Oleanic acid_10μM_rep2","GSM2286335","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Oleanic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286335/suppl/GSM2286335_BH13773-3_D9-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Oleanic acid"
"GSM2286336","MCF7_Phillyrin_10μM_rep1","GSM2286336","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Phillyrin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286336/suppl/GSM2286336_BH13773-3_D10-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Phillyrin"
"GSM2286337","MCF7_Phillyrin_10μM_rep2","GSM2286337","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Phillyrin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286337/suppl/GSM2286337_BH13773-3_D10-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Phillyrin"
"GSM2286338","MCF7_Curculigoside_10μM_rep1","GSM2286338","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Curculigoside","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286338/suppl/GSM2286338_BH13774-3_D11-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Curculigoside"
"GSM2286339","MCF7_Curculigoside_10μM_rep2","GSM2286339","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Curculigoside","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286339/suppl/GSM2286339_BH13774-3_D11-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Curculigoside"
"GSM2286340","MCF7_Scutellarein_10μM_rep1","GSM2286340","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Scutellarein","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286340/suppl/GSM2286340_BH13774-3_D12-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Scutellarein"
"GSM2286341","MCF7_Scutellarein_10μM_rep2","GSM2286341","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Scutellarein","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286341/suppl/GSM2286341_BH13774-3_D12-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Scutellarein"
"GSM2286342","MCF7_β-ecdysterone_10μM_rep1","GSM2286342","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: β-ecdysterone","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286342/suppl/GSM2286342_BH13774-3_D13-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","β-ecdysterone"
"GSM2286343","MCF7_β-ecdysterone_10μM_rep2","GSM2286343","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: β-ecdysterone","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286343/suppl/GSM2286343_BH13774-3_D13-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","β-ecdysterone"
"GSM2286344","MCF7_Strychnine_10μM_rep1","GSM2286344","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Strychnine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286344/suppl/GSM2286344_BH13774-3_D14-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Strychnine"
"GSM2286345","MCF7_Strychnine_10μM_rep2","GSM2286345","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Strychnine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286345/suppl/GSM2286345_BH13774-3_D14-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Strychnine"
"GSM2286346","MCF7_Magnolol_10μM_rep1","GSM2286346","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Magnolol","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286346/suppl/GSM2286346_BH13774-3_D15-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Magnolol"
"GSM2286347","MCF7_Magnolol_10μM_rep2","GSM2286347","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Magnolol","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286347/suppl/GSM2286347_BH13774-3_D15-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Magnolol"
"GSM2286348","MCF7_Honokiol_10μM_rep1","GSM2286348","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Honokiol","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286348/suppl/GSM2286348_BH14332-3_D16-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Honokiol"
"GSM2286349","MCF7_Honokiol_10μM_rep2","GSM2286349","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Honokiol","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286349/suppl/GSM2286349_BH14332-3_D16-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Honokiol"
"GSM2286350","MCF7_Geniposide_10μM_rep1","GSM2286350","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Geniposide","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286350/suppl/GSM2286350_BH14332-3_D17-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Geniposide"
"GSM2286351","MCF7_Geniposide_10μM_rep2","GSM2286351","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Geniposide","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286351/suppl/GSM2286351_BH14332-3_D17-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Geniposide"
"GSM2286352","MCF7_Gallic acid_10μM_rep1","GSM2286352","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Gallic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286352/suppl/GSM2286352_BH14332-3_D18-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Gallic acid"
"GSM2286353","MCF7_Gallic acid_10μM_rep2","GSM2286353","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Gallic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286353/suppl/GSM2286353_BH14332-3_D18-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Gallic acid"
"GSM2286354","MCF7_Notoginsenoside R1_10μM_rep1","GSM2286354","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Notoginsenoside R1","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286354/suppl/GSM2286354_BH14332-3_D19-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Notoginsenoside R1"
"GSM2286355","MCF7_Notoginsenoside R1_10μM_rep2","GSM2286355","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Notoginsenoside R1","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286355/suppl/GSM2286355_BH14332-3_D19-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Notoginsenoside R1"
"GSM2286356","MCF7_Liquiritin_10μM_rep1","GSM2286356","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Liquiritin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286356/suppl/GSM2286356_BH14332-3_D20-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Liquiritin"
"GSM2286357","MCF7_Liquiritin_10μM_rep2","GSM2286357","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Liquiritin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286357/suppl/GSM2286357_BH14332-3_D20-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Liquiritin"
"GSM2286358","MCF7_L-scopolamine_10μM_rep1","GSM2286358","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: L-scopolamine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286358/suppl/GSM2286358_BH14336-3_D21-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","L-scopolamine"
"GSM2286359","MCF7_L-scopolamine_10μM_rep2","GSM2286359","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: L-scopolamine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286359/suppl/GSM2286359_BH14336-3_D21-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","L-scopolamine"
"GSM2286360","MCF7_Gentiopicroside_10μM_rep1","GSM2286360","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Gentiopicroside","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286360/suppl/GSM2286360_BH14336-3_D22-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Gentiopicroside"
"GSM2286361","MCF7_Gentiopicroside_10μM_rep2","GSM2286361","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Gentiopicroside","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286361/suppl/GSM2286361_BH14336-3_D22-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Gentiopicroside"
"GSM2286362","MCF7_Benzoylhypaconitine_10μM_rep1","GSM2286362","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Benzoylhypaconitine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286362/suppl/GSM2286362_BH14336-3_D23-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Benzoylhypaconitine"
"GSM2286363","MCF7_Benzoylhypaconitine_10μM_rep2","GSM2286363","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Benzoylhypaconitine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286363/suppl/GSM2286363_BH14336-3_D23-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Benzoylhypaconitine"
"GSM2286364","MCF7_Benzoylaconitine_10μM_rep1","GSM2286364","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Benzoylaconitine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286364/suppl/GSM2286364_BH14336-3_D24-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Benzoylaconitine"
"GSM2286365","MCF7_Benzoylaconitine_10μM_rep2","GSM2286365","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Benzoylaconitine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286365/suppl/GSM2286365_BH14336-3_D24-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Benzoylaconitine"
"GSM2286366","MCF7_Tetrahydropalmatine_10μM_rep1","GSM2286366","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Tetrahydropalmatine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286366/suppl/GSM2286366_BH14336-3_D25-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Tetrahydropalmatine"
"GSM2286367","MCF7_Tetrahydropalmatine_10μM_rep2","GSM2286367","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Tetrahydropalmatine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286367/suppl/GSM2286367_BH14336-3_D25-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Tetrahydropalmatine"
"GSM2286368","MCF7_Hypaconitine_10μM_rep1","GSM2286368","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Hypaconitine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286368/suppl/GSM2286368_BH14340-3_D26-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Hypaconitine"
"GSM2286369","MCF7_Hypaconitine_10μM_rep2","GSM2286369","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Hypaconitine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286369/suppl/GSM2286369_BH14340-3_D26-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Hypaconitine"
"GSM2286370","MCF7_Glycyrrhizic acid_10μM_rep1","GSM2286370","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Glycyrrhizic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286370/suppl/GSM2286370_BH14340-3_D27-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Glycyrrhizic acid"
"GSM2286371","MCF7_Glycyrrhizic acid_10μM_rep2","GSM2286371","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Glycyrrhizic acid","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286371/suppl/GSM2286371_BH14340-3_D27-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Glycyrrhizic acid"
"GSM2286372","MCF7_6-gingerol_10μM_rep1","GSM2286372","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: 6-gingerol","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286372/suppl/GSM2286372_BH14340-3_D28-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","6-gingerol"
"GSM2286373","MCF7_6-gingerol_10μM_rep2","GSM2286373","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: 6-gingerol","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286373/suppl/GSM2286373_BH14340-3_D28-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","6-gingerol"
"GSM2286374","MCF7_Macrozamin_10μM_rep1","GSM2286374","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Macrozamin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286374/suppl/GSM2286374_BH14340-3_D29-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Macrozamin"
"GSM2286375","MCF7_Macrozamin_10μM_rep2","GSM2286375","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Macrozamin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286375/suppl/GSM2286375_BH14340-3_D29-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Macrozamin"
"GSM2286376","MCF7_Sennoside A_10μM_rep1","GSM2286376","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Sennoside A","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286376/suppl/GSM2286376_BH14340-3_D30-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Sennoside A"
"GSM2286377","MCF7_Sennoside A_10μM_rep2","GSM2286377","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Sennoside A","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286377/suppl/GSM2286377_BH14340-3_D30-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Sennoside A"
"GSM2286378","MCF7_Oridonin_1μM_rep1","GSM2286378","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Oridonin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286378/suppl/GSM2286378_BH14340-3_D31-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Oridonin"
"GSM2286379","MCF7_Oridonin_1μM_rep2","GSM2286379","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Oridonin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286379/suppl/GSM2286379_BH14340-3_D31-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Oridonin"
"GSM2286380","MCF7_Dioscin_1μM_rep1","GSM2286380","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Dioscin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286380/suppl/GSM2286380_BH14340-3_D32-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Dioscin"
"GSM2286381","MCF7_Dioscin_1μM_rep2","GSM2286381","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Dioscin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286381/suppl/GSM2286381_BH14340-3_D32-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Dioscin"
"GSM2286382","MCF7_(+)2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeate_10μM_rep1","GSM2286382","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: (+)2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeate","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286382/suppl/GSM2286382_BH14340-3_D33-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","(+)2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeate"
"GSM2286383","MCF7_(+)2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeate_10μM_rep2","GSM2286383","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: (+)2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeate","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286383/suppl/GSM2286383_BH14340-3_D33-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","(+)2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeate"
"GSM2286384","MCF7_Bruceine D_10μM_rep1","GSM2286384","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Bruceine D","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286384/suppl/GSM2286384_BH14340-3_D34-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Bruceine D"
"GSM2286385","MCF7_Bruceine D_10μM_rep2","GSM2286385","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Bruceine D","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286385/suppl/GSM2286385_BH14340-3_D34-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Bruceine D"
"GSM2286386","MCF7_Narciclasine_10μM_rep1","GSM2286386","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Narciclasine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286386/suppl/GSM2286386_BH14340-3_D35-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Narciclasine"
"GSM2286387","MCF7_Narciclasine_10μM_rep2","GSM2286387","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Narciclasine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286387/suppl/GSM2286387_BH14340-3_D35-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Narciclasine"
"GSM2286388","MCF7_Santonin_10μM_rep1","GSM2286388","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Santonin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286388/suppl/GSM2286388_BH14340-3_D36-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Santonin"
"GSM2286389","MCF7_Santonin_10μM_rep2","GSM2286389","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Santonin","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286389/suppl/GSM2286389_BH14340-3_D36-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Santonin"
"GSM2286390","MCF7_Ainsliadimer A_1μM_rep1","GSM2286390","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ainsliadimer A","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286390/suppl/GSM2286390_BH14340-3_D37-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ainsliadimer A"
"GSM2286391","MCF7_Ainsliadimer A_1μM_rep2","GSM2286391","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Ainsliadimer A","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286391/suppl/GSM2286391_BH14340-3_D37-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Ainsliadimer A"
"GSM2286392","MCF7_Chelerythrine_1μM_rep1","GSM2286392","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Chelerythrine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286392/suppl/GSM2286392_BH14340-3_D38-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Chelerythrine"
"GSM2286393","MCF7_Chelerythrine_1μM_rep2","GSM2286393","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Chelerythrine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286393/suppl/GSM2286393_BH14340-3_D38-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Chelerythrine"
"GSM2286394","MCF7_Sanguinarine_1μM_rep1","GSM2286394","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Sanguinarine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286394/suppl/GSM2286394_BH14340-3_D39-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Sanguinarine"
"GSM2286395","MCF7_Sanguinarine_1μM_rep2","GSM2286395","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: treatment","perturbagen: Sanguinarine","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286395/suppl/GSM2286395_BH14340-3_D39-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Sanguinarine"
"GSM2286396","MCF7_Four mixture_rep1","GSM2286396","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","MCF7_Four mixture(Tanshinone IIA:Salvianic acid A sodium:Protocatechuic aldehyde:Salvianolic acid B=1:1:1:1）_10μM_rep1","Homo sapiens","group: treatment","perturbagen: Four mixture(Tanshinone IIA:Salvianic acid A sodium:Protocatechuic aldehyde:Salvianolic acid B=1:1:1:1)","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286396/suppl/GSM2286396_BH14340-3_D41-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Four mixture(Tanshinone IIA:Salvianic acid A sodium:Protocatechuic aldehyde:Salvianolic acid B=1:1:1:1)"
"GSM2286397","MCF7_Four mixture_rep2","GSM2286397","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","MCF7_Four mixture(Tanshinone IIA:Salvianic acid A sodium:Protocatechuic aldehyde:Salvianolic acid B=1:1:1:1）_10μM_rep2","Homo sapiens","group: treatment","perturbagen: Four mixture(Tanshinone IIA:Salvianic acid A sodium:Protocatechuic aldehyde:Salvianolic acid B=1:1:1:1)","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286397/suppl/GSM2286397_BH14340-3_D41-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","treatment","Four mixture(Tanshinone IIA:Salvianic acid A sodium:Protocatechuic aldehyde:Salvianolic acid B=1:1:1:1)"
"GSM2286398","MCF7_vehicle(DMSO)_rep1 [BH14340-3_D]","GSM2286398","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: control","perturbagen: DMSO","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286398/suppl/GSM2286398_BH14340-3_D-DMSO-1_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","control","DMSO"
"GSM2286399","MCF7_vehicle(DMSO)_rep2 [BH14340-3_D]","GSM2286399","Public on Mar 26 2017","Aug 19 2016","Mar 26 2017","RNA","1","Human breast cancer cell line MCF7","Homo sapiens","group: control","perturbagen: DMSO","cell line: breast cancer cell line MCF7","duration: 12 h","The MCF7 cells were treated by 102 molecules at 10μM or 1μM, DMSO, and 10μM mixture of four compounds (1:1:1:1) for 12h.","The MCF7 cells were cultured in MEM/EBSS supplemented with 10% fetal bovine serum, 1mmol/L sodium pyruvate, 0.1mmol/L MEM non-essential amino acids, 100 unit/mL penicillin, and 100 mg/mL streptomycin in a incubator containing 5% CO2 at 37℃.","total RNA","Total RNA was extracted using TRIZOL Reagent (Cat#15596-018，Life technologies, Carlsbad, CA, US)following the manufacturer’s instructions and checked for a RIN number to inspect RNA integrity by an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US).Qualified total RNA was further purified by RNeasy micro kit (Cat#74004, QIAGEN, GmBH, Germany) and RNase-Free DNase Set  (Cat#79254, QIAGEN, GmBH, Germany).","biotin","Total RNA were amplified, labeled and purified by using GeneChip 3’IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions to obtain biotin labeled cRNA.","9606","Array hybridization and wash was performed using GeneChip® Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.","Slides were scanned by GeneChip® Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US)","Gene expression data from human breast cancer cell line MCF7","Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).","GPL571","chao,,lv","lvchaoanhui@163.com","18321786576","School of Pharmacy","Second Military Medical University","No. 325, Guohe Rd","Shanghai","None Selected","200433","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2286nnn/GSM2286399/suppl/GSM2286399_BH14340-3_D-DMSO-2_HG-U133A_2_.CEL.gz","22277","breast cancer cell line MCF7","12 h","control","DMSO"
